针对细胞内天生的RNA传感系统克服了对固体瘤CAR T细胞治疗的抗性
Nardine Soliman1, Tatiana Nedelko2, Giada Mandracci3
1Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.
Cancer research
|April 30, 2025
概括
由于细胞死亡途径受损,CAR T细胞疗法在固体瘤中扎. 在瘤中激活RIG-I/MAVS系统通过促进癌细胞死亡来提高CAR T细胞的有效性.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 在血液癌症中,CAR T细胞疗法显示出很大的前景,但在固体瘤中取得的成功有限.
- 瘤内在的抵抗机制,特别是缺陷的细胞死亡途径,阻碍了CAR T细胞的疗效.
- 天生的免疫传感在固体瘤内CAR-T细胞抵抗中的作用是一个正在积极研究的领域.
研究的目的:
- 研究RIG-I/MAVSRNA传感途径在瘤细胞对CAR T细胞疗法的抵抗性中的作用.
- 确定是否针对RIG-I/MAVS途径可以克服耐药性并增强固体瘤中的CAR T细胞活性.
主要方法:
- 利用各种小鼠和人类癌症模型来评估CAR T细胞的反应.
- 研究了RIG-I/MAVS信号活动对瘤细胞易受CAR T细胞中介杀伤的影响.
- 在瘤微环境中采用RIG-I途径的激素介导向.
主要成果:
- 瘤细胞中RIG-I/MAVS活动不足,使其对CAR-T细胞的攻击具有内在的抵抗力.
- 活跃的RIG-I/MAVS信号使瘤细胞发生亡,并增强对CAR T细胞的敏感性.
- 准RIG-I通路使黑色素瘤等固体瘤对CAR T细胞治疗敏感,改善CAR T细胞透和活动.
结论:
- 损坏的RIG-I/MAVS信号传递和下游细胞死亡途径代表了固体瘤中对CAR T细胞治疗的关键抵抗机制.
- 激活瘤内在的RIG-I信号是一种有前途的策略,可以提高实体瘤的敏感性,并提高CAR T细胞治疗的疗效.
更多相关视频
09:56A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
Published on: February 21, 2025
374
11:08Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
Published on: February 14, 2025
586
相关概念视频
Tumor Immunotherapy
397
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
397
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Cytotoxic T Cells-mediated Immune Response
720
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
720
Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K
Cells of the Innate Immune Response
1.1K
The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
1.1K
Experimental RNAi
6.0K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.0K
